Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
15.74 (USD) • At close July 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.551 | 240.735 | 243.231 | 138.287 | 87.992 | 168.796 | 16.142 | 31.408 | 0.158 | 0.382 | 0.175 | 0.29 | 0.147 | 0.296 | 0.62 | 3.758 | 1.303 | 1.208 | 0.595 | 0.591 | 0.196 | 0 | 0.002 | 0.009 | 0.025 | 0.037 | 0.06 | 0.077 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.724 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0.002 | 0.003 | 0.007 | 0.037 |
| Gross Profit
| 3.551 | 240.735 | 243.231 | 138.287 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.147 | 0.296 | 0.62 | 3.758 | 0 | 0.484 | 0 | 0 | 0 | 0 | 0.002 | 0.003 | 0.023 | 0.034 | 0.054 | 0.04 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0.401 | 0 | 0 | 0 | 0 | 0.962 | 0.324 | 0.916 | 0.923 | 0.889 | 0.517 |
| Reseach & Development Expenses
| 505.87 | 353.188 | 297.307 | 206.342 | 128.875 | 81.049 | 52.969 | 50.904 | 62.118 | 57.41 | 23.138 | 8.706 | 5.391 | 3.278 | 1.111 | 8.893 | 12.145 | 20.931 | 9.037 | 3.754 | 0.793 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 96.82 | 90.932 | 124.431 | 80.981 | 52.276 | 26.556 | 19.11 | 17.499 | 23.595 | 34.718 | 24.42 | 11.693 | 14.096 | 6.581 | 7.995 | 14.039 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.056 | 0.04 | 0.011 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.034 | 0.038 | 0.078 |
| SG&A
| 96.82 | 90.932 | 124.431 | 80.981 | 52.276 | 26.556 | 19.11 | 17.499 | 23.595 | 34.718 | 24.42 | 11.693 | 14.096 | 6.581 | 7.995 | 14.039 | 23.751 | 17.087 | 11.651 | 6.248 | 2.094 | 0.091 | 0.144 | 0.109 | 0.132 | 0.09 | 0.078 | 0.09 |
| Other Expenses
| 1.941 | 1.617 | 0 | 0 | 0 | 0 | 0 | 0 | -5.862 | 4.228 | 3.721 | 3.173 | 1.749 | 0.268 | 0 | 0.387 | 0.41 | 0.416 | 0.391 | 0.182 | 0 | 0 | 1.275 | 0 | 0 | 0 | 0 | 0.108 |
| Operating Expenses
| 604.631 | 445.737 | 421.738 | 287.323 | 181.151 | 107.605 | 72.079 | 68.404 | 79.85 | 96.356 | 51.279 | 23.571 | 21.236 | 10.126 | 9.422 | 23.318 | 36.306 | 38.433 | 21.079 | 10.184 | 2.887 | 0.094 | 1.418 | 0.109 | 0.132 | 0.09 | 0.078 | 0.198 |
| Operating Income
| -601.08 | -205.002 | -178.507 | -149.036 | -93.159 | 61.191 | -55.936 | -36.996 | -81.743 | -95.974 | -53.276 | -24.589 | -21.089 | -9.83 | -8.802 | -19.56 | -35.003 | -37.949 | -20.483 | -9.593 | -2.691 | -0.094 | -1.416 | -0.106 | -0.109 | -0.056 | -0.024 | -0.159 |
| Operating Income Ratio
| -169.271 | -0.852 | -0.734 | -1.078 | -1.059 | 0.363 | -3.465 | -1.178 | -516.271 | -251.241 | -304.436 | -84.713 | -143.586 | -33.195 | -14.195 | -5.205 | -26.859 | -31.414 | -34.399 | -16.24 | -13.707 | 0 | -624.984 | -11.412 | -4.391 | -1.519 | -0.402 | -2.071 |
| Total Other Income Expenses Net
| -11.38 | -1.489 | 5.798 | 8.19 | 8.608 | 6.958 | 1.488 | 2.618 | 0.022 | 4.035 | -5.444 | -7.114 | -1.021 | 1.045 | 1.466 | 19.56 | 35.003 | 37.949 | 20.483 | 9.593 | 0.195 | 0 | 1.17 | -0.08 | -0.028 | -0.312 | -0.141 | 0.159 |
| Income Before Tax
| -612.46 | -206.491 | -172.709 | -140.846 | -84.551 | 68.149 | -54.448 | -34.378 | -81.721 | -91.938 | -58.72 | -31.703 | -22.111 | -8.785 | 0 | 0 | 0 | 0 | 0 | 0 | -2.496 | -0.094 | -0.246 | -0.186 | -0.138 | -0.368 | -0.165 | 0 |
| Income Before Tax Ratio
| -172.475 | -0.858 | -0.71 | -1.019 | -0.961 | 0.404 | -3.373 | -1.095 | -516.131 | -240.677 | -335.543 | -109.221 | -150.541 | -29.665 | 0 | 0 | 0 | 0 | 0 | 0 | -12.716 | 0 | -108.653 | -19.955 | -5.529 | -9.959 | -2.733 | 0 |
| Income Tax Expense
| -2.767 | 2.784 | 3.785 | 0.002 | 0.002 | 0.174 | 0.002 | 0.002 | 0.002 | 0.002 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -599.493 | -205.275 | -176.063 | -140.848 | -84.553 | 67.975 | -54.45 | -34.38 | -81.723 | -91.941 | -58.63 | -31.143 | -21.126 | -3.129 | -5.774 | -19.308 | -27.089 | -29.931 | -18.997 | -6.855 | -2.528 | -0.095 | -0.246 | -0.186 | -0.138 | 0.593 | -0.165 | -0.855 |
| Net Income Ratio
| -168.824 | -0.853 | -0.724 | -1.019 | -0.961 | 0.403 | -3.373 | -1.095 | -516.146 | -240.683 | -335.03 | -107.292 | -143.836 | -10.566 | -9.312 | -5.138 | -20.787 | -24.777 | -31.904 | -11.605 | -12.879 | 0 | -108.653 | -19.955 | -5.529 | 16.028 | -2.733 | -11.157 |
| EPS
| -5 | -1.91 | -1.67 | -1.36 | -0.84 | 0.72 | -0.65 | -0.47 | -1.34 | -1.6 | -1.25 | -1.3 | -1.9 | -0.44 | -0.9 | -4.27 | -6.91 | -8.35 | -5.95 | -2.61 | -1.88 | -11.78 | -32.47 | -25.97 | -19.48 | 59.3 | -5.16 | -85.45 |
| EPS Diluted
| -5 | -1.92 | -1.67 | -1.36 | -0.84 | 0.69 | -0.65 | -0.47 | -1.34 | -1.6 | -1.25 | -1.3 | -1.9 | -0.44 | -0.9 | -4.27 | -6.91 | -8.35 | -5.95 | -2.61 | -1.88 | -11.78 | -32.47 | -25.97 | -19.48 | 59.3 | -5.16 | -85.45 |
| EBITDA
| -561.513 | -175.672 | -162.288 | -132.579 | -87.217 | 65.63 | -51.237 | -32.305 | -76.432 | -93.638 | -49.758 | -21.53 | -19.34 | -9.562 | -9.833 | -18.565 | -33.869 | -36.945 | -19.596 | -8.949 | -2.616 | -0.094 | -1.407 | -0.103 | -0.102 | -0.048 | -0.015 | -0.055 |
| EBITDA Ratio
| -158.128 | -0.73 | -0.667 | -0.959 | -0.991 | 0.389 | -3.174 | -1.029 | -482.729 | -245.125 | -284.333 | -74.173 | -131.678 | -32.29 | -15.857 | -4.94 | -25.989 | -30.583 | -32.91 | -15.15 | -13.327 | 0 | -620.978 | -11.033 | -4.084 | -1.3 | -0.25 | -0.716 |